联系客服

002644 深市 佛慈制药


首页 公告 佛慈制药:2024年半年度财务报告

佛慈制药:2024年半年度财务报告

公告日期:2024-08-27

佛慈制药:2024年半年度财务报告 PDF查看PDF原文

        (2024 年 1 月 1 日至 2024 年 6 月 30 日止)

      目  录                                    页 次
一、 财务报表

      合并资产负债表                            1-2

      合并利润表                                  3

      合并现金流量表                              4

      合并所有者权益变动表                      5-6

      母公司资产负债表                          7-8

      母公司利润表                                9

      母公司现金流量表                            10

      母公司所有者权益变动表                    11-12
二、  财务报表附注                              13-84

                    合并资产负债表

                                  2024年6月30日

 编制单位:兰州佛慈制药股份有限公司                                              金额单位:人民币元

                  项  目                      注释      2024年6月30日        2024年1月1日

流动资产:

 货币资金                                        五、1          362,369,100.93        406,040,604.70

 交易性金融资产
 衍生金融资产
 应收票据

 应收账款                                        五、2          327,882,275.47        285,487,599.46

 应收款项融资                                    五、3          29,664,020.67          97,163,546.77

 预付款项                                        五、4          17,218,331.12          17,062,096.92

 其他应收款                                      五、5          36,081,145.12          42,098,745.16

 其中:应收利息

    应收股利

 存货                                            五、6          418,135,714.66        369,720,187.96

 合同资产
 持有待售资产
 一年内到期的非流动资产

 其他流动资产                                    五、7          25,927,552.66          21,296,541.87

                  流动资产合计                                1,217,278,140.63      1,238,869,322.84

非流动资产:
 债权投资
 其他债权投资
 长期应收款

 长期股权投资                                    五、8          60,656,787.90          64,103,030.98

 其他权益工具投资
 其他非流动金融资产

 投资性房地产                                    五、9            7,908,166.23          8,116,873.48

 固定资产                                        五、10        1,039,106,917.53      1,056,198,751.95

 在建工程                                        五、11            2,626,417.24          3,299,498.18

 生产性生物资产
 油气资产

 使用权资产                                      五、12            1,903,626.45          2,337,536.94

 无形资产                                        五、13          78,552,506.17          79,551,495.79

 开发支出

 商誉                                            五、14            9,009,586.84          9,009,586.84

 长期待摊费用                                    五、15            5,492,213.94          7,654,824.09

 递延所得税资产                                  五、16          55,772,493.32          53,648,272.25

 其他非流动资产                                  五、17            6,114,238.27          5,313,021.02

                非流动资产合计                                1,267,142,953.89      1,289,232,891.52

                  资产总计                                    2,484,421,094.52      2,528,102,214.36

  法定代表人:单小东            主管会计工作负责人:岳金风              会计机构负责人: 王婷


  (承上页)

                        合并资产负债表(续)

                                            2024年6月30日

 编制单位:兰州佛慈制药股份有限公司                                                                金额单位:人民币元

                    项  目                      注释          2024年6月30日                2024年1月1日

 流动负债:

 短期借款                                        五、18                  10,000,000.00                10,000,000.00

 交易性金融负债
 衍生金融负债

 应付票据                                        五、19                                                27,434,000.00

 应付账款                                        五、20                297,117,035.49                282,938,778.50

 预收款项

 合同负债                                        五、21                  31,181,370.87                47,017,257.29

 应付职工薪酬                                    五、22                  3,078,574.00                  4,185,589.19

 应交税费                                        五、23                  19,524,088.42                35,125,433.42

 其他应付款                                      五、24                  40,997,711.32                40,458,857.09

 其中:应付利息

      应付股利

 持有待售负债

 一年内到期的非流动负债                          五、25                  14,073,467.71                14,685,728.18

 其他流动负债                                    五、26                  3,691,521.82                  5,841,866.89

                  流动负债合计                                          419,663,769.63                467,687,510.56

 非流动负债:
 长期借款
 应付债券
 其中:优先股

      永续债

 租赁负债                                          五、27                  1,459,793.10                  1,345,791.72

 长期应付款                                      五、28                  13,200,000.00                26,600,000.00

 长期应付职工薪酬
 预计负债

 递延收益                                        五、29                256,584,553.63                260,964,150.35

 递延所得税负债                                  五、16                  2,842,524.00                  3,074,827.24

 其他非流动负债

                  非流动负债合计                                          274,086,870.73                291,984,769.31

                      负债合计                     
[点击查看PDF原文]